Supply Chain Interruptions/ Recalls

Supply Chain Interruptions/ Recalls

Welcome to our dedicated page for Supply Chain Interruptions and Recalls in the dialysis industry. Here, you'll find the latest updates and critical information about disruptions and recalls affecting dialysis supplies and equipment. Our goal is to keep you informed and prepared, ensuring that you can manage your operations smoothly and maintain the highest standards of patient care despite unforeseen challenges. 

Last updated 3/25/25.

CLICK HERE TO SUBMIT UPDATES 

.

Drug Shortages

January 15 (Revised): Cipla Limited, Hydrocortisone Sodium Succinate, Injection. Limited Availability, 1-3 months. 

January 14 (Revised): Hospira, Dobutamine Hydrochloride, Unavailable or discontinued. 

Unavailable

  • In Dextrose 5% In Plastic Container, Injection, 250 mg/250mL, 500 mg/250mL, and 1,000 mg/250mL. 
    • Next Delivery April 2026. Estimated Recovery June 2026
  • Injection, 250 mg/20mL (12.5 mg/1 mL) (NDC 0409-2344-88). Next delivery and estimated recovery December 2027. 

.

.

If you have information on a dialysis-related supply chain interruption, recall, correction, shortage, or discontinuation, please submit here.

If you have any questions, please contact marketing@renalhealthcare.org.

.